Open AccessNew features combined neuroprotective therapy in patients with chronic stroke against the background of cardiovascular pathology
Author(s) -
N. Svyrydova,
N. Zhhilova
Publication year - 2017
Publication title -
shìdno-êvropejsʹkij nevrologìčnij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2663-8444
pISSN - 2411-5797
DOI - 10.33444/2411-5797.2017.1(13).9-16
Subject(s) - nootropic , neuroprotection , medicine , stroke (engine) , anxiety , disease , cognition , intensive care medicine , pharmacotherapy , neuroscience , neuroimaging , physical medicine and rehabilitation , bioinformatics , physical therapy , psychiatry , psychology , mechanical engineering , engineering , biology
In this article discusses the study of the drug Olatropil on the dynamics of the functional state of the brain in patients with chronic stroke against the background of cardiovascular disease. It has been proved the impact of dysfunction autonomic nervous system on the emergence of cognitive and psycho-emotional disorders that can serve as an early diagnostic criterion to identify these disorders Application of of combined nootropic medicinal drugs Olatropil in a complex treatment has a reliable positive impact on the dynamics of the functional state of the brain, gives true opportunity to decline and progression in patients with worsening opportunities switch to different activities, reducing the need for activity and communicating with increasing sensitivity to setbacks and high self-control. It has been shown that using of Olatropil in treatment of these patients improves treatment efficacy as a whole by restoring 1) vegetative lability, 2) improving cognitive function, and 3) reducing anxiety.